Physician profile
Michael David Tseng
NPI 1801002175
$12,911.53
in general payments reported to CMS, 2019-2025
13 companies · $1,757 in 2025
The $1,757 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,618 · 2020: $1,144 · 2021: $3,279 · 2022: $794 · 2023: $1,544 · 2024: $775 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,237 · Food and Beverage: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,237.23 |
| Food and Beverage | $839.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,881.64 | 2021-2024 | Other - Miscellaneous |
| Globus Medical, INC. | $3,429.34 | 2019-2025 | Reline, Attrax |
| Amplify Surgical, INC. | $1,408.92 | 2025 | |
| Stryker Corporation | $1,295.48 | 2019-2024 | Capri Corpectomy Cage System, Everest Spinal System |
| Zimmer Biomet Holdings, INC. | $809.73 | 2020 | |
| Highridge Medical LLC | $283.96 | 2024 | Mobi-C Plug & Fit US |
| Medtronic, INC. | $269.27 | 2024-2025 | Navlock, Anteralign Spinal System With Titan Nanolock Surface Technology, Midas Rex |
| Intrinsic Therapeutics | $220.72 | 2020 | |
| Medtronic USA, INC. | $118.28 | 2019 | |
| Evolution Surgical, INC | $109.74 | 2024-2025 | |
| Surgalign Spine Technologies, INC. | $39.16 | 2020 | |
| Abbvie INC. | $29.59 | 2024 | |
| Boston Scientific Corporation | $15.70 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.